U.S., July 28 -- ClinicalTrials.gov registry received information related to the study (NCT07726966) titled 'Betacyanin for Early Diagnosis and Recovery of Anastomotic Leakage After Rectal Cancer Surgery: A Single-Center, Prospective, Controlled Trial' on July 21.
Brief Summary: This single-center, prospective, controlled trial compares betacyanin versus conventional methods for early diagnosis and healing assessment of anastomotic leakage after rectal cancer surgery.
Study Start Date: Aug. 20
Study Type: INTERVENTIONAL
Condition:
Rectum Cancer
Anastomotic Leak
Intervention:
DIETARY_SUPPLEMENT: Betacyanin
200 mL oral betacyanin solution administered daily from postoperative day 3 until discharge or confirmation of anastomotic leakag...